Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby

LOBBYING REGISTRATION

Lobbying Disclosure Act of 1995 (Section 4)

Check One: New Registrant New Client for Existing Registrant Amendment

1. Effective Date of Registration
06/01/2009
2. House Identification
 375230000
 Senate Identification
 296533-12

REGISTRANT Organization/Lobbying Firm Self Employed Individual

3. Registrant Organization
OSI Pharmaceuticals, Inc.
Address
41 Pinelawn Road
 Address2
​
City
Melville
 State
NY
 Zip
11747
 Country
USA

4. Principal place of business (if different than line 3)

City
​
 State
​
 Zip
​
 Country
​
5. Contact name and telephone number International Number
Contact
​Ms. Kimberly Linthicum
 Telephone
​2029977117
 E-mail
​klinthicum@ospi.com
6. General description of registrant’s business or activities
​Discovery and development of innovative molecular targeted therapies

CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self

7. Client name
​OSI Pharmaceuticals, Inc.
Address
​
City
​
 State
​
 Zip
​
 Country
​USA
8. Principal place of business (if different than line 7)
City
​
 State
​
 Zip
​
 Country
​
9. General description of client’s business or activities
​

LOBBYISTS

10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.

Name Covered Official Position (if applicable)
First
Last
Suffix
​Kimberly ​Linthicum ​ ​Legislative Director, Rep Bob Franks (1997-2000)
​Kimberly ​Linthicum ​ ​Legislative Correspondent, Rep Charles Taylor (1997)
​Kimberly ​Linthicum ​ ​Legislative Correspondent, Rep Bill Martini (1995-1996)
​ ​ ​ ​
​ ​ ​ ​

LOBBYING ISSUES

11. General lobbying issue areas (Select all applicable codes).

​HCR
​MMM
​CPT
​TAX
​TRD
​BUD
​
​
​

12. Specific lobbying issues (current and anticipated)

Medicare Part D (Medicare Prescription Drug Benefit), Medicare reimbursement for drugs & biologics, health insurance reform (ERISA & HIPPA), Medicaid rebate, 340b pricing program, importation, patent reform (Hatch-Waxman Act), corporate taxation, FDA funding, FDA authority, prescription drug user fees, PTO funding

AFFILIATED ORGANIZATIONS

13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?

No --> Go to line 14. Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14.
Internet Address:
​
Name Address Principal Place of Business
Street
City State/Province Zip Code Country
​
​
City
​
​
​
​
​
State
​
 Country
​
​
​
City
​
​
​
​
​
State
​
 Country
​
​
​
City
​
​
​
​
​
State
​
 Country
​

FOREIGN ENTITIES

14. Is there any foreign entity

a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or

b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or

c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?

No --> Sign and date the registration. Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration.
Address Ownership
Name Street Principal place of business Amount of contribution
City State/Province Country
(city and state or country) for lobbying activities
​
City
​
​
​
​
​
State
​
 Country
​
​
​
 %
​
City
​
​
​
​
​
State
​
 Country
​
​
​
 %
Signature
Digitally Signed By: Kimberly Linthicum, Senior Director, Government Affairs
 Date
06/29/2009